Monthly Archives: August 2008

Genentech Committee Responds to Roche Purchase Proposal

Genentech’s special committee formed to help the Board of Directors pose a response to the Roche purchase proposal has stated that they feel the offer "substantially undervalues" the company, but left open the door for a new bid.  Here is … Continue reading

Posted in Business/Industry News | 1 Comment

With a Untitled Letter, Does FDA Set New Policy on Stem Cell Use in the United States?

Here is a newsbreaker I think. Stem cells hold a great deal of promise in research and clinical trials are underway around the world to make that promise a reality.  However, many entrepreneurial efforts have been underway to use stem … Continue reading

Posted in Biologics | 4 Comments

Cardiome and Astellas Announce Receipt of FDA Approvable Letter for KYNAPID

Today is supposed to mark the day that the FDA quits submitting approvable letters and starts issuing "complete response letters" – but it looks like one flew off the shelf just in the nick of time – at least per … Continue reading

Posted in Approvable Letters | Comments Off on Cardiome and Astellas Announce Receipt of FDA Approvable Letter for KYNAPID

Warning Letter Summary – Second Quarter 2008

Warning letters from the FDA’s DDMAC have only been at the pace of a trickle under the Bush Administration, and the second quarter was no exception, though there was at least one interesting lesson to be learned. In April, DDMAC … Continue reading

Posted in Warning Letters | 1 Comment

Weekly Roundup – 08/08/08

It is Triple 8 today.  It is Friday.  Congress is gone.  The humidity has fallen and the high tomorrow is only supposed to be 80.  (Congress leaves, so does hot air).  There is every reason to feel right with the … Continue reading

Posted in Weekly Roundup | Comments Off on Weekly Roundup – 08/08/08